KRYSTIN MALBON: Open Payments
NPI 1942858691 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,147 in 52 payments from 10 companies in 2025. Trend: 2023 $593 · 2024 $657 · 2025 $1,147
Food & beverage: $1,147
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $359 |
| ABBVIE INC. | 15 | $255 |
| PFIZER INC. | 6 | $129 |
| Lilly USA, LLC | 5 | $107 |
| Novo Nordisk Inc | 5 | $104 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Exact Sciences Corporation | 2 | $35 |
| Amgen Inc. | 1 | $18 |
| Endo USA, Inc. | 1 | $17 |
Products named: AIRSUPRA, VRAYLAR, NURTEC ODT, BREZTRI, UBRELVY, MOUNJARO, XIFAXAN, Ozempic.
Industry payments across VA — which companies pay providers there.
